Finance

Lists
Outlook: 66.7% bullish·0.0% bearish
Go to analysis
AHR:NYSE
American Healthcare REIT Inc
$59.23
0.00%
(0.00) 1D
$58.80
-0.73% (-0.43)
Pre-market
Closed: Nov 11, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AHR...
Mkt. cap
13.75B
Avg. vol.
3.22M
Volume
1.06K
Dividend
1.69%
Quarterly dividend
$0.25
Ex-dividend date
Sep 30, 2026
P/E ratio
121.34
52-wk high
$59.53
52-wk low
$44.81
EPS
$0.49
Shares outstanding
232.07M
No. of employees
121
Mkt. cap
13.75B
Avg. vol.
3.22M
Volume
1.06K
Dividend
1.69%
Quarterly dividend
$0.25
Ex-dividend date
Sep 30, 2026
P/E ratio
121.34
52-wk high
$59.53
52-wk low
$44.81
EPS
$0.49
Shares outstanding
232.07M
No. of employees
121
News stories
From web sources and news partners
About American Healthcare REIT Inc
CEO-
Employees121
Founded2006
HeadquartersIrvine, California, United States
SectorReal Estate
IndustryReal estate investment trust
Analyst ratings
Based on 11 analysts giving stock ratings to AHR in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for AHR in the last 3 months.
Highest
Current $59.23
$71.00 (+19.87%)
Average
$63.70 (+7.55%)
Lowest
$55.00 (-7.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Goldsmith
UBS
Buy
Reiterated
$71.00
+19.9%
11/11/2026
Nicholas Joseph
Citi
Buy
Maintained
$67.00
+13.1%
11/10/2026
Michael Carroll
RBC Capital
Buy
Reiterated
$66.00
+11.4%
11/09/2026
Nicholas Yulico
Scotiabank
Buy
Maintained
$62.00
+4.7%
11/06/2026
Dave Rodgers
Raymond James
Buy
Initiated
$62.00
+4.7%
10/13/2026
Richard Hightower
Barclays
Buy
Maintained
$60.00
+1.3%
10/13/2026
Juan C. Sanabria
BMO Capital
Buy
Reiterated
$65.00
+9.7%
10/02/2026
Farrell Granath
Bank of America Securities
Buy
Maintained
-
-
09/14/2026
Austin Wurschmidt
KeyBanc
Buy
Reiterated
$68.00
+14.8%
08/19/2026
Ronald Kamdem
Morgan Stanley
Buy
Reiterated
$55.00
-7.1%
08/17/2026
Michael Lewis
Truist Financial
Buy
Reiterated
$61.00
+3%
08/14/2026
Barry Oxford
Colliers Securities
Buy
Maintained
$65.00
+9.7%
08/07/2026
Aaron Hecht
Citizens JMP
Buy
Maintained
$65.00
+9.7%
07/27/2026
Rob Simone
Compass Point
Buy
Initiated
$70.00
+18.2%
07/21/2026
Seth Bergey
Citi
Buy
Upgraded
$55.00
-7.1%
06/23/2026
Last report
Nov 6, 2026
Fiscal period
Q3 2026
$0.13 / $0.16
-16.81%miss
Revenue / Est. (USD)
742.20M / 724.84M
+2.39%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
604.74M
651.57M
675.14M
742.20M
Cost of goods sold
492.50M
525.27M
537.01M
577.35M
Cost of revenue
492.50M
525.27M
537.01M
577.35M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.53M
17.60M
19.89M
21.58M
Operating expense
71.85M
84.67M
92.02M
112.45M
Total operating expenses
564.35M
609.94M
629.03M
689.80M
Operating income
40.38M
41.63M
46.12M
52.39M
Other non operating income
375.00K
3.86M
2.27M
3.37M
EBT including unusual items
8.52M
23.49M
30.98M
32.26M
EBT excluding unusual items
20.95M
25.88M
29.84M
37.37M
Income tax expense
-2.42M
-525.00K
-3.00K
740.00K
Effective tax rate
-28.33%
-2.24%
-0.01%
2.29%
Other operating expenses
-
-
-
-
Net income
10.78M
23.71M
30.61M
31.21M
Net profit margin
1.78%
3.64%
4.53%
4.21%
Earnings per share
0.14
0.14
0.15
0.13
Interest and investment income
-
-
-
-
Interest expense
-19.81M
-18.80M
-18.63M
-17.77M
Net interest expenses
-19.81M
-18.80M
-18.63M
-17.77M
Depreciation and amortization charges
55.32M
67.06M
72.12M
90.87M
EBITDA
105.55M
116.41M
125.87M
148.82M
Gain or loss from assets sale
621.00K
-
-5.65M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps